L.L. Siu

Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma

A. W. M. Lee, Shui‐Yi Tung, Dtt Chua et al. · JNCI Journal of the National Cancer Institute · 2010 · 321 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus

Ignacio Durán, L.L. Siu, Amit M. Oza et al. · European Journal of Cancer · 2006 · 152 citations

Medicine, Oncology, Pharmacology +14

Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors

Erkut Borazanci, Alison M. Schram, Elena Garralda et al. · ESMO Open · 2022 · 38 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors

C. Massard, Jean‐Charles Soria, Anastasios Stathis et al. · European Journal of Cancer · 2016 · 30 citations

Medicine, Oncology, Pharmacology +13

A phase II study of BAY 43–9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)

L.L. Siu, Eric Winquist, Mark Agulnik et al. · Journal of Clinical Oncology · 2005 · 11 citations

Medicine, Oncology, Pharmacology +17